Management of Cardiac Arrest - Flowchart
Management of Cardiac Arrest - Flowchart
«Flowchart»

Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Ventricular Fibrillation or Pulseless Ventricular Tachycardia

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

Continue chest compressions, intubate, IV access

Continue chest compressions, intubate, IV access

Continue chest compressions, intubate, IV access

FAIL

FAIL

FAIL

FAIL

Epinephrine, 1 mg IV -or- Vasopressin, 40 units IV; follow with repeat defibrillation at maximum energy within 30-60 s as required; repeat epinephrine

Epinephrine, 1 mg IV -or- Vasopressin, 40 units IV; follow with repeat defibrillation at maximum energy within 30-60 s as required; repeat epinephrine

Epinephrine, 1 mg IV -or- Vasopressin, 40 units IV; follow with repeat defibrillation at maximum energy within 30-60 s as required; repeat epinephrine

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

Amiodarone: 150 mg over 10 min, 1 mg/min
Lidocaine: 1.5 mg/kg; repeat in 3–5 min
Magnesium sulfate: 1–2 gm IV (polymorphic VT)
Procainamide: 30 mg/min, to 17 mg/kg [monomorphic VT]

Amiodarone: 150 mg over 10 min, 1 mg/min
Lidocaine: 1.5 mg/kg; repeat in 3–5 min
Magnesium sulfate: 1–2 gm IV (polymorphic VT)
Procainamide: 30 mg/min, to 17 mg/kg [monomorphic VT]

Amiodarone: 150 mg over 10 min, 1 mg/min
Lidocaine: 1.5 mg/kg; repeat in 3–5 min
Magnesium sulfate: 1–2 gm IV (polymorphic VT)
Procainamide: 30 mg/min, to 17 mg/kg [monomorphic VT]




Defibrillate, CPR: Drug-Shock-Drug-Shock

Defibrillate, CPR: Drug-Shock-Drug-Shock

Defibrillate, CPR: Drug-Shock-Drug-Shock

Antiarrhythmics

Antiarrhythmics

Antiarrhythmics

End

End

End

Immediate defibrillation within 5 min of onset; 60-90 seconds of CPR before defibrillation for delay 5 min

Immediate defibrillation within 5 min of onset; 60-90 seconds of CPR before defibrillation for delay 5 min

Immediate defibrillation within 5 min of onset; 60-90 seconds of CPR before defibrillation for delay 5 min

2 min of chest compressions at >100/min followed by repeat shock; repeat sequence twice if needed

2 min of chest compressions at >100/min followed by repeat shock; repeat sequence twice if needed

2 min of chest compressions at >100/min followed by repeat shock; repeat sequence twice if needed

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

If return of circulation fails

Epinephrine, dose

Epinephrine, dose

Epinephrine

Antiarrhythmics

Antiarrhythmics

Antiarrhythmics

NaHCO3, 1 meq/kg ( K+ ) (no longer for routine use; may be used for persistent acidosis-see text)

NaHCO3, 1 meq/kg ( K+ ) (no longer for routine use; may be used for persistent acidosis-see text)

3 + NaHCO(3)